Prospera Financial Services’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.75M | Buy |
|
|||||
|
2025
Q1 | $639K | Buy |
|
|||||
|
2024
Q4 | $509K | Sell |
|
|||||
|
2024
Q3 | $731K | Sell |
|
|||||
|
2024
Q2 | $770K | Buy |
|
|||||
|
2024
Q1 | $700K | Buy |
|
|||||
|
2023
Q4 | $484K | Sell |
|
|||||
|
2023
Q3 | $511K | Buy |
|
|||||
|
2023
Q2 | $492K | Buy |
|
|||||
|
2023
Q1 | $481K | Buy |
|
|||||
|
2022
Q4 | $438K | Buy |
|
|||||
|
2022
Q3 | $235K | Sell |
|
|||||
|
2022
Q2 | $445K | Sell |
|
|||||
|
2022
Q1 | $527K | Buy |
|
|||||
|
2021
Q4 | $501K | Buy |
|
|||||
|
2021
Q3 | $379K | Buy |
|
|||||
|
2021
Q2 | $384K | Buy |
|
|||||
|
2021
Q1 | $308K | Sell |
|
|||||
|
2020
Q4 | $322K | Buy |
|
|||||
|
2020
Q3 | $108K | Sell |
|
|||||
|
2020
Q2 | $284K | Sell |
|
|||||
|
2020
Q1 | $293K | Sell |
|
|||||
|
2019
Q4 | $423K | Buy |
|
|||||
|
2019
Q3 | $284K | Buy |
|
|||||
|
2019
Q2 | $254K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $284K | Sell |
|
|||||
|
2017
Q2 | $363K | Sell |
|
|||||
|
2017
Q1 | $730K | Sell |
|
|||||
|
2016
Q4 | $735K | Buy |
|
|||||
|
2016
Q3 | $777K | Buy |
|
|||||
|
2016
Q2 | $769K | Buy |
|
|||||
|
2016
Q1 | $686K | Buy |
|
|||||
|
2015
Q4 | $425K | Sell |
|
|||||
|
2015
Q3 | $431K | Buy |
|
|||||
|
2015
Q2 | $406K | Sell |
|
|||||
|
2015
Q1 | $450K | Sell |
|
|||||
|
2014
Q4 | $434K | Buy |
|
|||||
|
2014
Q3 | $381K | Buy |
|
|||||
|
2014
Q2 | $283K | Hold |
|
|||||
|
2014
Q1 | $282K | Buy |
|
|||||
|
2013
Q4 | $282K | Sell |
|
|||||
|
2013
Q3 | $286K | Sell |
|
|||||
|
2013
Q2 | $295K | Buy |
|